PacBio
Stock
Stock
Ticker: PACB
PACB
Price
Price
CHART BY
Frequently asked questions
What is PacBio's market capitalization?
The market capitalization of PacBio is $640.31M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for PacBio?
PacBio's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.431. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for PacBio's stock?
Currently, 8 analysts cover PacBio's stock, with a consensus target price of $2.543. Analyst ratings provide insights into the stock's expected performance.
What is PacBio's revenue over the trailing twelve months?
Over the trailing twelve months, PacBio reported a revenue of $159.27M.
What is the EBITDA for PacBio?
PacBio's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$144.81M. EBITDA measures the company's overall financial performance.
What is the free cash flow of PacBio?
PacBio has a free cash flow of -$123.42M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does PacBio have, and what sector and industry does it belong to?
PacBio employs approximately 485 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of PacBio's shares?
The free float of PacBio is 284.22M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $640.31M
- EPS (TTM)
- -$0.431
- Free Float
- 284.22M
- Revenue (TTM)
- $159.27M
- EBITDA (TTM)
- -$144.81M
- Free Cashflow (TTM)
- -$123.42M
Pricing
- 1D span
- $1.965$2.124
- 52W span
- $1.075$3.43
Analyst Ratings
The price target is $2.543 and the stock is covered by 8 analysts.
Buy
4
Hold
3
Sell
1
Information
Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.
- Employees
- 485
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- Primary Ticker
- PACB
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet